Cellectar Biosciences announces 1-for-30 reverse stock split; effective June 24, 2025

Cellectar Biosciences, Inc.

Approved by stockholders at June 13, 2025 annual meeting; board set final ratio as 1-for-30.
Reduces outstanding shares from ~54.4M to ~1.8M; effective at 12:01 a.m. ET on June 24.
Fractional shareholders will receive cash in lieu; authorized shares and par value unchanged.
Ticker remains CLRB on Nasdaq; new CUSIP number 15117F880 begins June 24.
Outstanding options, warrants, and preferred stock conversion ratios adjust proportionately.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.